The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare ...

After he stopped responding to several different therapies aimed at prolonging his life, doctors advised him to try a drug ...

The drugmaker has won an appeal against NICE's recent final draft guidance on Sarclisa (isatuximab) as a regimen alongside ...

The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...

Doctors use the presence of these symptoms to tell the difference between precancerous and cancerous disease and to guide treatment. Multiple myeloma activates cells that break down bone called ...

A case of a deadly new mpox strain has been detected in the UK for the first time ... Monkeypox is an infectious disease caused by the monkeypox virus. It can cause a painful rash, enlarged ...

Beyfortus is the first long-acting antibody approved in Canada for the prevention of RSV lower respiratory tract disease in newborns and infants through their first RSV season. Sanofi noted that ...

Myeloma UK estimates around 24,000 people are affected by the disease in the UK, with an estimated 5,900 new diagnoses each year. Caroline Donoghue, senior policy officer at the charity ...

“This is important considering the relapsing and remitting nature of the disease and the fact that patients continue to need additional options, especially as their cancer advances and stops ...